Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03634241
Brief Title: Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study

First Submitted : August 10, 2018
First Submitted that Met QC Criteria : August 14, 2018
First Posted : August 16, 2018

Last Update Submitted that Met QC Criteria : February 24, 2021
Last Update Posted : March 1, 2021